MBD5 Protein - Methyl-CpG Binding Domain Protein 5

Migration, Crosslink

📖

MBD5 Protein - Methyl-CpG Binding Domain Protein 5

active

wiki page Created: 2026-04-02T07:19:05 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-proteins-mbd5-protein

📖 Wiki Page

protein810 wordssynced 2026-04-02

MBD5 Protein - Methyl-CpG Binding Domain Protein 5

Introduction

Mbd5 Protein Methyl Cpg Binding Domain Protein 5 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-protein"> [@mbd2019]
<table> [@epigenetic2021]
<tr><th colspan="2" style="background:#f0f0f0;">MBD5 Protein</th></tr> [@microdeletion2018]
<tr><td><b>Protein Name</b></td><td>Methyl-CpG Binding Domain Protein 5</td></tr> [@chromatin2022]
<tr><td><b>Gene</b></td><td>MBD5</td></tr> [@mbd2021]
<tr><td><b>UniProt ID</b></td><td>Q9P2T1</td></tr>
<tr><td><b>Category</b></td><td>Epigenetic Regulator Protein</td></tr>
<tr><td><b>Path</b></td><td>/proteins/mbd5-protein</td></tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
</div>

Overview

MBD5 (Methyl-CpG Binding Domain Protein 5) is a chromatin-associated protein that plays a critical role in epigenetic regulation, neurodevelopment, and synaptic function. It is encoded by the MBD5 gene and is highly expressed in the brain, particularly during development. Mutations in MBD5 are a well-established cause of neurodevelopmental disorders including autism spectrum disorder (ASD) and intellectual disability (ID).

Structure

MBD5 contains several functional domains:

...

MBD5 Protein - Methyl-CpG Binding Domain Protein 5

Introduction

Mbd5 Protein Methyl Cpg Binding Domain Protein 5 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-protein"> [@mbd2019]
<table> [@epigenetic2021]
<tr><th colspan="2" style="background:#f0f0f0;">MBD5 Protein</th></tr> [@microdeletion2018]
<tr><td><b>Protein Name</b></td><td>Methyl-CpG Binding Domain Protein 5</td></tr> [@chromatin2022]
<tr><td><b>Gene</b></td><td>MBD5</td></tr> [@mbd2021]
<tr><td><b>UniProt ID</b></td><td>Q9P2T1</td></tr>
<tr><td><b>Category</b></td><td>Epigenetic Regulator Protein</td></tr>
<tr><td><b>Path</b></td><td>/proteins/mbd5-protein</td></tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
</div>

Overview

MBD5 (Methyl-CpG Binding Domain Protein 5) is a chromatin-associated protein that plays a critical role in epigenetic regulation, neurodevelopment, and synaptic function. It is encoded by the MBD5 gene and is highly expressed in the brain, particularly during development. Mutations in MBD5 are a well-established cause of neurodevelopmental disorders including autism spectrum disorder (ASD) and intellectual disability (ID).

Structure

MBD5 contains several functional domains:

Methyl-CpG binding domain (MBD): Located at the N-terminus, this domain binds specifically to methylated CpG dinucleotides

Proline-rich region: Mediates protein-protein interactions

ATN domain (Atrophin-1-like): Shared with other MBD family members, involved in transcriptional regulation

C-terminal region: Contains additional binding sites for chromatin-associated proteins

The protein has a molecular weight of approximately 225 kDa and localizes to the nucleus where it functions as a transcriptional regulator.

Function

Transcriptional Regulation

MBD5 acts as a transcriptional regulator through multiple mechanisms:

[DNA methylation](/entities/dna-methylation) binding: Recognizes methylated promoter regions and modulates gene expression
Chromatin remodeling recruitment: Recruits histone modifiers and chromatin remodelers
Gene-specific targeting: Regulates specific gene networks important for neuronal function

Neurodevelopmental Roles

MBD5 is essential for normal brain development:

Cortical development: Regulates neuronal proliferation and differentiation
Synaptogenesis: Important for proper synapse formation and function
Circuit formation: Guides development of neural circuits
Dendritic arborization: Influences dendritic morphology

Brain Expression

High expression in:

Cerebral [cortex](/brain-regions/cortex): Throughout all cortical layers
[Hippocampus](/brain-regions/hippocampus): Especially CA regions and dentate gyrus
Cerebellum: Purkinje cells and granule cells
Basal ganglia: Striatal medium spiny [neurons](/entities/neurons)
Developing brain: Peak expression during prenatal and early postnatal development

Role in Neurological Disease

Autism Spectrum Disorder (ASD)

MBD5 is one of the most significant ASD risk genes:

Heterozygous mutations: Cause haploinsufficiency leading to ASD
De novo variants: Predominantly de novo loss-of-function mutations
Penetrance: High penetrance for neurodevelopmental phenotypes
Phenotype spectrum: ASD with intellectual disability, speech delay

Intellectual Disability

MBD5 mutations are a common cause of nonsyndromic intellectual disability:

Severity: Ranges from mild to moderate ID
Co-occurring features: Often with speech impairment
Developmental trajectory: Early developmental delays, plateau in adolescence

MBD5 Encephalopathy

Also known as MBD5-associated neurodevelopmental disorder (MAND):

Epilepsy: Seizures in ~50% of cases
Motor delays: Hypotonia, motor coordination issues
Behavioral features: Anxiety, attention deficits, aggression
Regression: Some individuals show developmental regression

Sleep Disorders

Insomnia: Common sleep initiation problems
Circadian rhythm disturbances: Altered sleep-wake cycles
Treatable: Some respond to melatonin therapy

Genetic Associations

MBD5 Mutations

Mutation types: Missense, nonsense, frameshift, splice site
Hotspots: Throughout the coding sequence
Inheritance: Almost always de novo
Genotype-phenotype: No clear correlation between mutation type and severity

2q23.1 Microdeletion Syndrome

MBD5 is the critical gene in 2q23.1 microdeletion syndrome:

Contiguous gene deletion: Includes MBD5 and flanking genes
Phenotype overlap: Similar to MBD5 point mutations
Mechanism: Haploinsufficiency of MBD5

Therapeutic Implications

Current Approaches

Symptomatic treatment: Antiepileptic drugs for seizures
Behavioral interventions: Applied behavior analysis (ABA)
Speech therapy: Communication enhancement
Occupational therapy: Motor skills development

Emerging Therapies

Epigenetic drugs: [HDAC](/entities/hdac-enzymes) inhibitors under investigation
Gene therapy: Future potential for precision medicine
Targeted interventions: Understanding MBD5 downstream effects

Animal Models

Knockout mice: Mbd5+/- mice show cognitive deficits
Conditional knockouts: Brain-specific deletion replicates features
Zebrafish: Developmental studies showing conserved function

External Links

[UniProt Q9P2T1](https://www.uniprot.org/uniprot/Q9P2T1)
[NCBI Gene: MBD5](https://www.ncbi.nlm.nih.gov/gene)
[GeneReviews: MBD5-Related Neurodevelopmental Disorder](https://www.ncbi.nlm.nih.gov/books/NBK350556/)
[OMIM: MBD5](https://www.omim.org/entry/611472)

Background

The study of Mbd5 Protein Methyl Cpg Binding Domain Protein 5 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

References

[Unknown, MBD5 in neurodevelopment and autism (2020) (2020)](https://doi.org/10.1038/s41588-020-0592-7)

[Unknown, MBD5 encephalopathy: clinical features and genetics (2019) (2019)](https://doi.org/10.1016/j.ejmg.2019.04.004)

[Unknown, Epigenetic regulation in autism spectrum disorders (2021) (2021)](https://doi.org/10.1038/s41380-021-01170-4)

[Unknown, 2q23.1 microdeletion syndrome (2018) (2018)](https://doi.org/10.1002/ajmg.a.38626)

[Unknown, Chromatin and neurodevelopmental disorders (2022) (2022)](https://doi.org/10.1016/j.tins.2022.01.008)

[Unknown, MBD5 and synaptic function (2021) (2021)](https://doi.org/10.1002/jnr.24875)

📖 View canonical wiki page →

Related Entities

MBD5PROTEIN

▸Metadataorigin_type: v1_polymorphic_backfill

slug	proteins-mbd5-protein
kg_node_id	MBD5PROTEIN
entity_type	protein
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-8821b9b983f0
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'proteins-mbd5-protein'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

100%

Debates

0

Incoming

20

Outgoing

22

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

MBD5 Protein - Methyl-CpG Binding Domain Protein 5

MBD5 Protein - Methyl-CpG Binding Domain Protein 5

Introduction

Overview

Structure

MBD5 Protein - Methyl-CpG Binding Domain Protein 5

Introduction

Overview

Structure

Function

Transcriptional Regulation

Neurodevelopmental Roles

Brain Expression

Role in Neurological Disease

Autism Spectrum Disorder (ASD)

Intellectual Disability

MBD5 Encephalopathy

Sleep Disorders

Genetic Associations

MBD5 Mutations

2q23.1 Microdeletion Syndrome

Therapeutic Implications

Current Approaches

Emerging Therapies

Animal Models

See Also

External Links

Background

References

💬 Discussion